Tag: Kiran Mazumdar Shaw

Biocon subsidiary gets USFDA nod for generic drug for chronic heart failure

1 min read Last Updated : Sep 01 2024 | 10:35 PM IST Biotechnology firm Biocon said its subsidiary

Research-based incentives to develop innovative drugs can help the domestic pharmaceutical sector to be worth $200 billion by 2030,

Biologics major Bengaluru-based Biocon posted a 168 per cent year-on-year rise in its consolidated net profit for the September

India will be the shining light to the world driven by its youth who are ‘driving startups’ India will be